Who is sponsoring NCT04916431?

NCT04916431 is sponsored by ModernaTX, Inc..

What condition does NCT04916431 study?

NCT04916431 studies Healthy Volunteers.

What is the status of NCT04916431?

NCT04916431 is currently COMPLETED.

Last reviewed 2022-08-10 · How we verify

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-6231 in Healthy Adults

NCT04916431 PHASE1 COMPLETED

There are 2 parts to this study: a single ascending dose (single dose of mRNA-6231) part and a multiple ascending dose (repeat doses of mRNA-6231) part. The main goal of this study is to evaluate the safety and tolerability of escalating doses of single and repeat subcutaneous (SC) administration of mRNA-6231. Dose levels of mRNA-6231 are planned to be investigated in a dose-escalation manner.

Details

Lead sponsor	ModernaTX, Inc.
Phase	PHASE1
Status	COMPLETED
Enrolment	18
Start date	Wed Jul 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Healthy Volunteers

Interventions

mRNA-6231

Countries

Australia